IRIS UniCatt

Bria, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.903
AS - Asia 5.334
EU - Europa 3.403
SA - Sud America 1.308
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 16.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.691
SG - Singapore 2.348
BR - Brasile 1.098
CN - Cina 973
IT - Italia 861
VN - Vietnam 718
SE - Svezia 664
FR - Francia 375
DE - Germania 356
IN - India 317
IE - Irlanda 187
PL - Polonia 187
GB - Regno Unito 186
BD - Bangladesh 185
ID - Indonesia 156
FI - Finlandia 147
HK - Hong Kong 137
JP - Giappone 137
RU - Federazione Russa 92
CA - Canada 88
AR - Argentina 87
MX - Messico 78
NL - Olanda 70
IQ - Iraq 66
KR - Corea 52
ES - Italia 44
AT - Austria 41
TR - Turchia 40
ZA - Sudafrica 38
EC - Ecuador 33
UA - Ucraina 32
CI - Costa d'Avorio 31
PK - Pakistan 28
CO - Colombia 24
IR - Iran 24
CZ - Repubblica Ceca 23
VE - Venezuela 23
BE - Belgio 22
SA - Arabia Saudita 21
UZ - Uzbekistan 19
LT - Lituania 18
CH - Svizzera 16
EG - Egitto 16
KE - Kenya 14
TN - Tunisia 14
PY - Paraguay 13
CL - Cile 12
JO - Giordania 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
PH - Filippine 11
PT - Portogallo 10
AL - Albania 9
DZ - Algeria 9
NP - Nepal 9
RO - Romania 9
AZ - Azerbaigian 8
BO - Bolivia 8
CR - Costa Rica 8
HU - Ungheria 8
JM - Giamaica 8
AU - Australia 7
BG - Bulgaria 6
KZ - Kazakistan 6
LV - Lettonia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
LB - Libano 5
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
LU - Lussemburgo 4
PA - Panama 4
PE - Perù 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
GD - Grenada 2
GE - Georgia 2
GG - Guernsey 2
HR - Croazia 2
MY - Malesia 2
PS - Palestinian Territory 2
Totale 16.084
Salva come PNG Salva come JPEG
Città #
Singapore 1.295
Ashburn 650
San Jose 584
Chandler 550
Ho Chi Minh City 237
Beijing 232
Rome 226
New York 200
Dublin 178
Hanoi 178
Warsaw 172
Fairfield 163
Hyderabad 156
Los Angeles 147
Hefei 139
Lauterbourg 136
Tokyo 134
Council Bluffs 127
Hong Kong 123
Jakarta 123
The Dalles 116
Chicago 104
Frankfurt am Main 104
Milan 103
Wilmington 103
São Paulo 102
Houston 98
Princeton 91
San Mateo 84
Helsinki 82
Seattle 81
Munich 76
Dallas 72
Boston 68
Moscow 57
Woodbridge 57
Santa Clara 53
Seoul 50
Boardman 49
Cambridge 48
London 45
St Louis 45
Ann Arbor 43
Cattolica 43
Paris 42
Buffalo 40
Marseille 40
Orem 40
Kent 38
Atlanta 35
Turku 34
Abidjan 31
Lappeenranta 31
Chennai 30
Da Nang 30
Bremen 29
Haiphong 29
Rio de Janeiro 29
Denver 28
Nuremberg 28
Brooklyn 26
Düsseldorf 26
Mexico City 26
Redwood City 25
Dearborn 24
Poplar 24
Nanjing 23
Stockholm 23
Johannesburg 22
Montreal 22
Toronto 22
Brussels 21
Curitiba 20
Goiânia 20
North Bergen 20
Phoenix 20
Hải Dương 19
San Francisco 19
Vienna 19
Amsterdam 18
Campinas 18
Manchester 18
Salt Lake City 18
Augusta 17
Dhaka 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Jacksonville 16
Andover 15
Guangzhou 15
Memphis 15
Porto Alegre 15
Shanghai 15
Brno 14
Hangzhou 14
Quito 14
Redmond 14
Riyadh 14
Kish 13
Totale 8.808
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 347
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 310
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 251
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 225
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 210
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 198
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 188
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 185
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 176
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 172
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 169
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 168
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 166
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 163
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 160
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 159
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series 157
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 155
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 155
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 154
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 151
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 151
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 146
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 145
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 144
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 144
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 139
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 138
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 138
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 138
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 137
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 135
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 135
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 134
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 133
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 133
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 132
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 131
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 128
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study 127
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 127
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 127
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 124
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy? 122
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 120
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial 120
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 120
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 119
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 118
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 118
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 117
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 116
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 116
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 116
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 115
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 114
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 114
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 110
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 109
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 109
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 109
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 109
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 108
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 108
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 108
Exploring the molecular and biological background of lung neuroendocrine tumours 108
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 108
Nutritional Support in Lung Cancer Patients: The State of the Art 108
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 107
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 106
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 106
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: The crucial role of histological type, number of resected nodes and adjuvant therapy 106
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 105
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer 105
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 105
Collagenous colitis and atezolizumab therapy: an atypical case. 105
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study 104
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 102
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 101
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 101
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 99
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 96
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 96
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 96
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 95
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 95
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 94
PTEN in colorectal cancer: Shedding light on its role as predictor and target 93
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 91
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 91
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 90
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 90
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 90
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 89
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study 85
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 84
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 83
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 83
Totale 13.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/2022914 107 39 18 101 37 38 23 139 48 27 157 180
2022/20231.699 266 207 134 241 75 201 99 125 176 57 67 51
2023/20241.055 36 250 39 49 41 114 108 53 17 56 128 164
2024/20253.079 88 42 204 99 177 80 152 117 460 453 639 568
2025/20268.567 1.016 324 606 1.286 1.288 359 1.278 408 560 526 409 507
Totale 16.408